Clinical Trials Browser

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT00080938 2023-06-29

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Adenocarcinoma of Lung, Brain Neoplasms, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00740636 2016-08-01

Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

Phase 2 Completed

92 enrolled 7 charts

Thoracic

Lung Neoplasms

NCT00005037 2014-05-06

Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Phase 2 Completed

51 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00006877 2014-01-08

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

Phase 2 Completed

30 enrolled

Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00022711 2013-07-11

Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer

Phase 2 Completed

7 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00003062 2012-07-02

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Phase 2 Completed

70 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00238251 2012-06-05

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases

Phase 2 Completed

59 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Clinical Trials

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer

Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases